Inspire Medical Systems (NYSE:INSP) Stock Breaks Below Two Hundred Day Moving Average – Here’s What Happened

Inspire Medical Systems, Inc. (NYSE:INSP – Get Free Report)’s stock price passed below its 200-day moving average during trading on Thursday. The stock has a 200-day moving average of $57.31 and traded as low as $55.54. Inspire Medical Systems shares last traded at $56.5140, with a volume of 614,737 shares.

Wall Street Analysts Forecast Growth

A number of equities analysts recently issued reports on INSP shares. Oppenheimer raised shares of Inspire Medical Systems from a “market perform” rating to an “outperform” rating and set a $85.00 price objective on the stock in a report on Tuesday, August 4th. Truist Financial reissued a “hold” rating and set a $76.00 price objective (down from $78.00) on shares of Inspire Medical Systems in a research report on Tuesday, November 3rd. Robert W. Baird upped their price target on Inspire Medical Systems from $73.00 to $77.00 and gave the stock a “neutral” rating in a research report on Tuesday, November 3rd. Mizuho set a $75.00 price target on Inspire Medical Systems in a research report on Tuesday, October 13th. Finally, Zacks Research downgraded Inspire Medical Systems from a “strong-buy” rating to a “hold” rating in a research note on Tuesday, September 22nd. One research analyst has rated the stock with a Strong Buy rating, three have given a Buy rating, twelve have issued a Hold rating and four have assigned a Sell rating to the company’s stock. According to MarketBeat, the stock currently has a consensus rating of “Hold” and an average price target of $71.24.

Read Our Latest Research Report on INSP

Inspire Medical Systems Stock Down 2.3%

The stock has a market capitalization of $1.59 billion, a PE ratio of 15.98, a PEG ratio of 4.32 and a beta of 0.67. The stock’s 50 day moving average price is $68.05 and its 200-day moving average price is $57.22.

Inspire Medical Systems (NYSE:INSP – Get Free Report) last posted its quarterly earnings results on Monday, November 2nd. The company reported $0.14 EPS for the quarter, beating analysts’ consensus estimates of $0.09 by $0.05. Inspire Medical Systems had a return on equity of 7.32% and a net margin of 11.43%. The business had revenue of $206.69 million for the quarter, compared to analysts’ expectations of $204.31 million. During the same period last year, the firm earned $0.38 earnings per share. The business’s quarterly revenue was down 7.9% on a year-over-year basis. On average, analysts forecast that Inspire Medical Systems, Inc. will post 1.29 earnings per share for the current year.

Institutional Inflows and Outflows

A number of institutional investors and hedge funds have recently modified their holdings of INSP. BlackRock Inc. purchased a new stake in Inspire Medical Systems during the second quarter valued at $211,341,000. Goldman Sachs Group Inc. increased its holdings in Inspire Medical Systems by 77.7% during the 3rd quarter. Goldman Sachs Group Inc. now owns 1,147,831 shares of the company’s stock worth $79,614,000 after purchasing an additional 501,973 shares during the period. William Blair Investment Management LLC bought a new position in shares of Inspire Medical Systems during the third quarter valued at approximately $44,362,000. Assenagon Asset Management S.A. increased its holdings in shares of Inspire Medical Systems by 66.2% in the 2nd quarter. Assenagon Asset Management S.A. now owns 864,395 shares of the company’s stock valued at $38,561,000 after acquiring an additional 344,221 shares during the period. Finally, UBS AM a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC grew its position in shares of Inspire Medical Systems by 21.7% in the 2nd quarter. UBS AM a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC now owns 546,020 shares of the company’s stock worth $24,358,000 after buying an additional 97,233 shares during the last quarter. 94.91% of the stock is owned by hedge funds and other institutional investors.

Inspire Medical Systems Company Profile

(Get Free Report)

Inspire Medical Systems is a medical technology company focused on treatments for obstructive sleep apnea, a condition in which breathing repeatedly stops or becomes restricted during sleep. Founded in 2007 and based in Minnesota, the company develops implantable devices intended for certain patients who cannot use or benefit from conventional positive airway pressure therapy. Its primary product, the Inspire Upper Airway Stimulation system, uses an implanted device to monitor breathing and deliver mild stimulation to the hypoglossal nerve, helping keep the airway open during sleep.

Further Reading

Receive News & Ratings for Inspire Medical Systems Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Inspire Medical Systems and related companies with MarketBeat.com's FREE daily email newsletter.